Net Loss of Orchid Pharma reported to Rs 22.66 crore in the quarter ended June 2020 as against net loss of Rs 38.45 crore during the previous quarter ended June 2019. Sales declined 12.01% to Rs 119.16 crore in the quarter ended June 2020 as against Rs 135.42 crore during the previous quarter ended June 2019.

Powered by Capital Market - Live News

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 7 September 2020.

Powered by Capital Market - Live News

Net Loss of Orchid Pharma reported to Rs 54.31 crore in the quarter ended March 2020 as against net loss of Rs 13.45 crore during the previous quarter ended March 2019. Sales declined 32.06% to Rs 110.11 crore in the quarter ended March 2020 as against Rs 162.07 crore during the previous quarter ended March 2019.

For the full year,net loss reported to Rs 149.84 crore in the year ended March 2020 as against net loss of Rs 101.05 crore during the previous year ended March 2019. Sales declined 13.40% to Rs 505.45 crore in the year ended March 2020 as against Rs 583.65 crore during the previous year ended March 2019.

Powered by Capital Market - Live News

Net Loss of Orchid Pharma reported to Rs 34.75 crore in the quarter ended December 2019 as against net loss of Rs 18.47 crore during the previous quarter ended December 2018. Sales declined 13.38% to Rs 128.58 crore in the quarter ended December 2019 as against Rs 148.45 crore during the previous quarter ended December 2018.

Powered by Capital Market - Live News